Previous 10 | Next 10 |
2024-01-25 14:20:00 ET Summary With a lead asset in advanced Phase-III testing, CG Oncology, which debuts Thursday on the NASDAQ, is one of the year’s most highly anticipated IPOs. The company’s lead drug targets a sizable addressable market (NMIBC) where there is an...
2024-01-22 11:54:46 ET More on highly-shorted stocks Spirit Airlines: Don't Join The Panic Spirit Airlines: Ch.11 Bankruptcy Could Be A Better Option To Save The Airline Assessing JetBlue Airways During A Time Of Significant Uncertainty Over Spirit Airlines Turmoil ...
2024-01-17 15:09:43 ET More on crowded shorts VinFast's Warm Reception In Contrast To Cold Shoulder Chinese EV Makers Are Getting ImmunityBio: Approval Likely Priced In, Yielding Mostly Risk For Would-Be Buyers Beyond Meat: No Path To Recovery VinFast Auto la...
2024-01-02 16:55:53 ET Gainers: Bloomin' Brands ( BLMN ) +6% . Arcutis Biotherapeutics ( ARQT ) +6% . Stronghold Digital Mining ( SDIG ) +5% . Longboard Pharmaceuticals ( LBPH ) +4% . Guardant Health ( GH ) +3% . Losers: ...
2024-01-02 06:11:57 ET More on ImmunityBio ImmunityBio: Approval Likely Priced In, Yielding Mostly Risk For Would-Be Buyers ImmunityBio: On The Verge, But With Many Questions Remaining ImmunityBio: The CRL Makes It Riskier Than Ever ImmunityBio gains as bladd...
2023-12-23 07:00:00 ET More on Carvana Carvana: Kicking The Can Down The Road Carvana's Controversial Journey: Why I'm Still Bullish Despite Debt Exchange, Carvana Is Still Not A Buy Auto retail stocks gain after better-than-feared earnings report from CarMax...
2023-12-22 04:16:14 ET Summary ImmunityBio is a late-stage biotech company focused on developing immunotherapy approaches for cancer treatment. The company's main product of interest is Anktiva, a fusion protein designed to stimulate an antitumor response in bladder cancer patient...
2023-11-22 17:09:08 ET Gainers: Aurora Innovation ( AUR ) +2% . Innodata ( INOD ) +2% . The Vita Coco Company ( COCO ) +2% . Immunovant ( IMVT ) +2% . The RealReal ( REAL ) +2% . Losers: BioCryst Pharmaceuticals ( ...
ImmunityBio, Inc. ( NASDAQ: IBRX ), a clinical-stage immunotherapy company, announced today that the company will be participating in the 35 th Annual Piper Sandler Healthcare Conference, which is taking place in New York City, November 28-30, 2023. Details of the presentation can be ...
ImmunityBio Inc. (IBRX) is expected to report $-0.27 for Q3 2023
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 01:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into ImmunityBio, Inc. (NasdaqGS: IBRX). On May 11, 2023, the Company disclosed that it had receiv...